TNH HOSPITAL GROUP ORGANIZES SCIENTIFIC SEMINAR ON THE APPLICATION OF PRP AND HA IN THE TREATMENT OF MUSCULOSKELETAL DISORDERS

On June 18, 2026, TNH Hospital Group Joint Stock Company, in collaboration with Haliphar Medical Trading and Investment Joint Stock Company, organized a scientific seminar entitled “The Application of Platelet-Rich Plasma (PRP) and PRP Combined with Hyaluronic Acid (HA) in the Treatment of Musculoskeletal Disorders,” while also conducting a technology transfer program for PRP preparation and injection techniques.

The seminar was held with the aim of updating the latest advances in the treatment of musculoskeletal disorders, providing a platform for professional exchange and practical experience sharing among healthcare professionals, and promoting the application of advanced medical technologies in clinical practice throughout the TNH healthcare system.

The event attracted the participation of leading experts, experienced speakers, and healthcare professionals from both within and outside the TNH system. The scientific program focused on current topics with high practical value and clinical applicability.

During the seminar, expert presentations provided comprehensive scientific insights into the role of PRP and PRP combined with HA in the management of musculoskeletal disorders. Speakers discussed the theoretical foundations, clinical effectiveness, and practical implementation experiences of these therapies, highlighting their potential benefits in modern medical practice.

In addition to the theoretical sessions, the program featured hands-on technology transfer activities, including PRP preparation, PRP injection, and combined HA-PRP injection procedures demonstrated through live clinical cases. These practical sessions enabled participating physicians to directly observe the techniques, engage in professional discussions, and gain a clearer understanding of the treatment processes.

Speaking at the seminar, Distinguished Physician and Specialist Level II Dr. Le Xuan Tan, Chief Executive Officer of TNH Hospital Group Joint Stock Company, emphasized the importance of continuously updating medical knowledge and adopting advanced treatment methods to enhance professional quality and better meet the growing healthcare needs of the community.

The seminar concluded successfully, delivering valuable scientific and professional content that contributed to improving the expertise of healthcare professionals while creating opportunities for collaboration, technology transfer, and the development of modern treatment techniques in the field of musculoskeletal medicine across the TNH healthcare system.

In the coming years, TNH Hospital Group will continue to strengthen its efforts in professional training, scientific research, and medical collaboration, with the goal of continuously improving healthcare quality and providing patients with access to advanced, effective, and safe treatment options.